SCHEMBL12417317

CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](C)CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N(C)[C@@H](CCCNC(=N)N)C(=O)NC(Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C

nearest known ligand 0.59

Predicted protein targets (top 4)

	gene	UniProt	supporting neighbours	confidence
▸	KISS1R	Q969F8	16/20	0.59

▸	IL23R	Q5VWK5	2/20	0.58

▸	NPY2R	P49146	2/20	0.57

▸	GHSR	Q92847	2/20	0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL12417440	1.00	KISS1R (0.59)	KISS1RIL23RNPY2RGHSR
SCHEMBL12417304	0.98	KISS1R (0.59)	KISS1RIL23RNPY2RGHSR
SCHEMBL12508019	0.98	KISS1R (0.59)	KISS1RIL23RNPY2RGHSR
SCHEMBL12417448	0.96	KISS1R (0.60)	KISS1RIL23RNPY2RGHSR
SCHEMBL12507812	0.96	KISS1R (0.60)	KISS1RIL23RNPY2RGHSR
SCHEMBL13248725	0.96	KISS1R (0.60)	KISS1RIL23RNPY2RGHSR
SCHEMBL29400476	0.96	KISS1R (0.60)	KISS1RIL23RNPY2RGHSR
SCHEMBL12417357	0.95	KISS1R (0.60)	KISS1RIL23RNPY2RGHSR
SCHEMBL13248741	0.93	KISS1R (0.58)	KISS1RIL23RNPY2RGHSR
SCHEMBL14498068	0.93	KISS1R (0.65)	KISS1RIL23R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20110172147-A1	NEUROPEPTIDE-2 RECEPTOR (Y-2R) AGONISTS	CONDE-KNAPE KARIN	2011-07-14	—	—	US	disclosed
US-20110172147-A1	NEUROPEPTIDE-2 RECEPTOR (Y-2R) AGONISTS	CONDE-KNAPE KARIN	2011-07-14	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20110172147-A1	NEUROPEPTIDE-2 RECEPTOR (Y-2R) AGONISTS	NPY2R, NPY1R, NPY4R	KISS1R 125/4885IL23R 550/4885NPY2R 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.